Covered recipient · General Payments record
JENNIFER WISE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$418.54
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $325.82 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $169.04 | 10 |
| Astellas Pharma US Inc | $42.16 | 2 |
| Exact Sciences Corporation | $35.15 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $32.12 | 1 |
| ABBVIE INC. | $24.58 | 1 |
| PFIZER INC. | $22.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.58 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108429164 | CMS |
| Astellas Pharma US Inc | $19.20 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139469926 | CMS |
| Astellas Pharma US Inc | $22.96 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139525026 | CMS |
| Boston Scientific Corporation | $32.12 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092458720 | CMS |
| Exact Sciences Corporation | $15.90 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114952308 | CMS |
| Exact Sciences Corporation | $19.25 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114952312 | CMS |
| Novo Nordisk Inc | $22.49 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100253680 | CMS |
| Novo Nordisk Inc | $21.64 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100573708 | CMS |
| Novo Nordisk Inc | $22.69 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100525935 | CMS |
| Novo Nordisk Inc | $9.90 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100517345 | CMS |
| Novo Nordisk Inc | $17.36 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100487123 | CMS |
| Novo Nordisk Inc | $4.27 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100229086 | CMS |
| Novo Nordisk Inc | $24.03 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100438021 | CMS |
| Novo Nordisk Inc | $7.03 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100328686 | CMS |
| Novo Nordisk Inc | $22.32 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100459666 | CMS |
| Novo Nordisk Inc | $17.31 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100655793 | CMS |
| PFIZER INC. | $22.77 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131608479 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.